Verici DX

VRCI · AIM · Health Care · mcap £8.9m · 0.2p 3 open situations →

EV: £6.7m
EV / EBIT: –
Net cash: £1.8m
FCF yield: -77.9%
Revenue: £2.6m
Share price 1y: −70%
Insiders 12m: no deals
Next report: around 28 Jun

Beta Briefing, track record and signals & risks are not ready for Verici DX yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation

dots = announcements

20252026 CANACCORD GENUITY GROUP INC selling down Harwood Capital LLP selling down Placing of 155% of the market value Results below expectations Results ahead of expectations Placing of 46% of the market value Results below expectations Placing of 62% of the market value Placing of 76% of the market value

Open · 3

Overhang

CANACCORD GENUITY GROUP INC selling down

11.0216% → 3.969% in 3 notices

Next: 3.969% still held

15 Oct 2026 3.969%
24 Jun 2026 6.8843%
31 Jul 2025 10.3825%
28 Jul 2025 11.0216%

Open the full view – chart and every step →

Overhang

Harwood Capital LLP selling down

15.5217% → 9.886% in 4 notices

Next: 9.886% still held

14 Oct 2026 9.886%
24 Jun 2026 11.967%
1 Oct 2025 12.756%
25 Jul 2025 13.074%

Open the full view – chart and every step →

Dilutive fundraise

Placing of 155% of the market value

completed

Verici DX is raising £8.0 million by placing, 155.4% of its market value, at a 11.1% discount; the shares moved +7% on the day.

13 Oct 2026 completed · +0% on the day
13 Oct 2026 completed · +0% on the day
9 Oct 2026 completed · +0% on the day
9 Oct 2026 announced · +0% on the day

Open the full view – chart and every step →

Closed · 6

Upgrade / downgrade cycleResults below expectations below expectations · second in 12 months · 29 Jun 2026 – 27 Sep 2026 −40% Upgrade / downgrade cycleResults ahead of expectations ahead of expectations · 16 Apr 2026 – 15 Jul 2026 −55% Dilutive fundraisePlacing of 46% of the market value completed · 5 Jun 2026 – 12 Jul 2026 −47% Upgrade / downgrade cycleResults below expectations below expectations · 5 Feb 2026 – 6 May 2026 −69% Dilutive fundraisePlacing of 62% of the market value completed · 30 Sep 2025 – 30 Oct 2025 −16% Dilutive fundraisePlacing of 76% of the market value completed · 11 Jun 2025 – 28 Aug 2025 −43%

Company filings. Not investment advice.